Literature DB >> 19410388

Verocytotoxin-producing Escherichia coli (VTEC).

Mohamed A Karmali1, Victor Gannon, Jan M Sargeant.   

Abstract

Escherichia coli O157:H7 and other Verocytotoxin-producing E. coli (VTEC) are zoonotic pathogens associated with food and waterborne illness around the world. E. coli O157:H7 has been implicated in large outbreaks as well as in sporadic cases of haemorrhagic colitis and the sometimes fatal haemolytic uremic syndrome. VTs produced by these bacteria are thought to damage host endothelial cells in small vessels of the intestine, kidney and brain resulting in thrombotic microangiopathy. All VTs have the same subunit structure, glycolipid cell receptor and inhibit protein synthesis. During VTEC infection, it is thought one or more bacterial adhesins initiates colonization and establishes intimate attachment and is responsible for the translocation of a variety of effectors which alter the structure and function of host cells. VTEC are widespread in animals but ruminants are thought to be their natural reservoir. E. coli O157:H7 colonizes the terminal colon of cattle and can be shed in very large numbers by specific herdmates known as "supershedders". Faeces containing these organisms act as a source of contamination for a variety of foods and the environment. Many VTEC control efforts have been investigated along the "farm to fork" continuum including, vaccination of cattle with colonization factors, and the use of novel antimicrobials, such as bacteriocins, chloral hydrate, bacteriophage and substances which disrupt quorum sensing. In addition, many barriers have been developed for use in the slaughter and food processing industry such as steam pasteurization and irradiation. Despite these efforts many scientific, technical and regulatory challenges remain in the control and prevention of VTEC-associated human illness. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19410388     DOI: 10.1016/j.vetmic.2009.04.011

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  128 in total

Review 1.  Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics.

Authors:  Tania N Petruzziello-Pellegrini; Philip A Marsden
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

Review 2.  Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae.

Authors:  Jessica Keithlin; Jan Sargeant; M Kate Thomas; Aamir Fazil
Journal:  Foodborne Pathog Dis       Date:  2013-11-27       Impact factor: 3.171

Review 3.  Glycosphingolipid functions.

Authors:  Clifford A Lingwood
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

4.  Gene cluster conferring streptomycin, sulfonamide, and tetracycline resistance in Escherichia coli O157:H7 phage types 23, 45, and 67.

Authors:  K Ziebell; R P Johnson; A M Kropinski; R Reid-Smith; R Ahmed; V P Gannon; M Gilmour; P Boerlin
Journal:  Appl Environ Microbiol       Date:  2011-01-14       Impact factor: 4.792

5.  Behavior of different Shiga toxin-producing Escherichia coli serotypes in various experimentally contaminated raw-milk cheeses.

Authors:  Stéphane D Miszczycha; Frédérique Perrin; Sarah Ganet; Emmanuel Jamet; Fanny Tenenhaus-Aziza; Marie-Christine Montel; Delphine Thevenot-Sergentet
Journal:  Appl Environ Microbiol       Date:  2012-10-19       Impact factor: 4.792

Review 6.  Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.

Authors:  Carlamaria Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2017-12-06       Impact factor: 3.714

Review 7.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

8.  Toxin production and antibiotic resistances in Escherichia coli isolated from bathing areas along the coastline of the Oslo fjord.

Authors:  Colin Charnock; Anne-Lise Nordlie; Bjarne Hjeltnes
Journal:  Curr Microbiol       Date:  2014-05-07       Impact factor: 2.188

9.  Minimizing human infection from Escherichia coli O157:H7 using GUMBOS.

Authors:  Marsha R Cole; Min Li; Ravirajsinh Jadeja; Bilal El-Zahab; Daniel Hayes; Jeffery A Hobden; Marlene E Janes; Isiah M Warner
Journal:  J Antimicrob Chemother       Date:  2013-02-26       Impact factor: 5.790

10.  Intimin gene (eae) subtype-based real-time PCR strategy for specific detection of Shiga toxin-producing Escherichia coli serotypes O157:H7, O26:H11, O103:H2, O111:H8, and O145:H28 in cattle feces.

Authors:  Delphine Bibbal; Estelle Loukiadis; Monique Kérourédan; Carine Peytavin de Garam; Franck Ferré; Philippe Cartier; Emilie Gay; Eric Oswald; Frédéric Auvray; Hubert Brugère
Journal:  Appl Environ Microbiol       Date:  2013-12-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.